Table 2.
Clinicopathologic features | OS | DFS | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Gender (male/female) | 0.869 | 0.518–1.457 | 0.594 | 1.028 | 0.591–1.789 | 0.923 |
Age (≤60/>60) | 0.915 | 0.550–1.522 | 0.733 | 0.709 | 0.404–1.244 | 0.230 |
Tumor size (cm) (>4.3/ ≤ 4.3) | 1.596 | 0.959–2.655 | 0.072 | 1.456 | 0.840–2.524 | 0.181 |
Differentiation degree (well/moderate + poor) | 0.901 | 0.530–1.532 | 0.700 | 1.054 | 0.600–1.850 | 0.855 |
T-stage (T3 + T4/T1 + T2) | 9.112 | 2.224–37.343 | 0.002 | 15.330 | 2.117–111.036 | 0.007 |
N-stage (N1 + N2/N0) | 4.047 | 2.359–6.944 | 0.000 | 3.369 | 1.902–5.967 | 0.000 |
M-stage (M1/M0) | 6.456 | 2.304–18.902 | 0.000 | 7.305 | 2.246–23.760 | 0.001 |
Nerve invasion (positive/negative) | 2.838 | 1.674–4.811 | 0.000 | 2.442 | 1.358–4.390 | 0.003 |
Vascular invasion (positive/negative) | 2.015 | 1.210–3.355 | 0.007 | 1.995 | 1.148–3.465 | 0.014 |
TNM stage (III + IV/I + II) | 4.332 | 2.507–7.487 | 0.000 | 3.333 | 1.881–5.905 | 0.000 |
NAPRT (high/low) | 2.622 | 1.459–4.713 | 0.001 | 2.765 | 1.468–5.210 | 0.002 |
NAMPT (high/low) | 3.518 | 2.085–5.935 | 0.000 | 3.05 | 1.743–5.337 | 0.000 |
OS, overall survival; DFS, disease- free survival. The bold values indicated that the P-value was smaller than 0.05.